Human umbilical cord mesenchymal stem cells pretreated with Angiotensin-II attenuate pancreas injury of rats with severe acute pancreatitis

Human umbilical cord mesenchymal stem cells pretreated with Angiotensin-II attenuate pancreas injury of rats with severe acute pancreatitis

Mesenchymal stem cells (MSCs) pretreatment is an effective route for improving cell-based therapy of endothelial cell survival, vascular stabilization, and angiogenesis. We hypothesized that the application of human umbilical cord-MSCs (hUC-MSCs) pretreated with angiotensin-II (Ang-II) might be a po...

Full description

Bibliographic Details
Main Authors: Jing Yang, Jun Su, Shao-Song Xi, Xian-Fu Ke, Ying Zhu, Hua-Peng Lin, Xiao-Kang Zeng, Bing-Wei Liu, Ming-Li Zhu, Wei-Ying Dai, Wei Hu
Format: Article
Language:English
Published: Elsevier 2019-09-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Angiotensin-II
hUC-MSCs
SAP
Angiogenesis
Endothelial cells
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332219309667

Internet

http://www.sciencedirect.com/science/article/pii/S0753332219309667

Similar Items